Drawing for ROBOTIC TISSUE

USPTO serial 79266002

ROBOTIC TISSUE

Reviewed by CopyMark Law Group

Reg. 6093106Status 711
Filing date
Status date
Registration date
Jul 7, 2020
Examiner
KLUWE, CHERYL D
Law office
Historical data usage

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ROBOTIC TISSUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Whittaker

Michael Whittaker Acuity Law Group162 S. Rancho Santa Fe Rd Ste E70-150Encinitas, CA 92024United States

Goods and services

ClassDescriptionStatusFirst use
005[ Allogeneic mammalian engineered biological tissue, in particular cultivated tissue with cardiac tissue for treating cardiac insufficiency; biological cultivated cardiac tissue of stem cells for treating cardiac insufficiency; biological cultivated liver tissue intended for subsequent implantation; biological cultivated kidney tissue for medical purposes; biological cultivated brain tissue intended for subsequent implantation; biological cultivated pancreatic tissue intended for subsequent implantation; biological cultivated lung tissue intended for subsequent implantation; biological cultivated muscle tissue intended for subsequent implantation; biological cultivated gastrointestinal tissue intended for subsequent implantation; biological cultivated neuronal tissue intended for subsequent implantation; biological cultivated skin tissue intended for subsequent implantation; biological cultivated bone tissue intended for subsequent implantation; biological cultivated bone marrow intended for subsequent implantation; biological cultivated fat tissue intended for subsequent implantation; biological cultivated connective tissue or biological cultivated blood vessel tissue, all intended for subsequent implantation; Gene therapy products, namely, genetically engineered living tissues for transplant purposes ]SECTION 7(e) - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026NCS7NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED—
Oct 19, 2026C7..CANCELLED SECTION 7-TOTAL—
Oct 19, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 26, 2026C7RFREQUEST FOR SECT 7 TOTAL SURRENDER FILED—
Aug 26, 2026ES7STEAS SECTION 7 SURRENDER RECEIVED—
Jul 7, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 21, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 4, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 4, 2020FIMPFINAL DISPOSITION PROCESSED—
Oct 7, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 7, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 26, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 26, 2019RFRRREFUSAL PROCESSED BY MPU—
Sep 13, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 12, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2019DOCKASSIGNED TO EXAMINER—
Sep 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance